Testing effectiveness (Phase 2)Ended earlyNCT00526071
What this trial is testing
Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study
Who this might be right for
Fabry Disease
Amicus Therapeutics 23